| scholarly article | Q13442814 |
| P2093 | author name string | Hideaki Oda | |
| Kazuho Honda | |||
| Yoshiharu Kato | |||
| Kenta Uto | |||
| Chiharu Aoki | |||
| P2860 | cites work | Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro | Q24314927 |
| Non-enzymatic glycosylation of a type I collagen matrix: effects on osteoblastic development and oxidative stress | Q24803063 | ||
| Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease | Q27000415 | ||
| Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) | Q28236767 | ||
| Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee | Q29616160 | ||
| Effects of trabecular type and orientation on microdamage susceptibility in trabecular bone | Q33788007 | ||
| Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures | Q33943363 | ||
| Bone fragility and collagen cross-links. | Q34586748 | ||
| Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings | Q35636589 | ||
| Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study | Q35678048 | ||
| Properties and Function of Lysyl Oxidase | Q36520735 | ||
| Bone changes in hemodialyzed uremic subjects. Comparative light and electron microscope investigations | Q36755317 | ||
| Lysyl oxidase binds transforming growth factor-beta and regulates its signaling via amine oxidase activity. | Q36990183 | ||
| Building strong bones: molecular regulation of the osteoblast lineage | Q37970567 | ||
| Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. | Q38700889 | ||
| Lysyl oxidase (lox) gene deficiency affects osteoblastic phenotype. | Q39224283 | ||
| Relationship between moderate to severe kidney disease and hip fracture in the United States | Q79150009 | ||
| Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism | Q79761766 | ||
| Increased risk of mortality associated with hip fracture in the dialysis population | Q80598163 | ||
| Advanced glycation endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts | Q81408826 | ||
| Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney disease | Q83598718 | ||
| Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosis | Q84823342 | ||
| Chronic kidney disease and hip fracture-related mortality in older people in the UK. | Q39305910 | ||
| Bone modelling processes at the endosteal surface of human femora. Scanning electron microscopical studies in normal bone and in renal osteodystrophy | Q39891664 | ||
| Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells | Q40013288 | ||
| A role for lysyl oxidase regulation in the control of normal collagen deposition in differentiating osteoblast cultures | Q40557286 | ||
| Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development | Q40752871 | ||
| Role of advanced glycation end products in adynamic bone disease in patients with diabetic nephropathy. | Q40778071 | ||
| Advanced glycation endproduct-specific receptors in rat and mouse osteoblast-like cells: regulation with stages of differentiation | Q40937294 | ||
| Homocysteine suppresses the expression of the collagen cross-linker lysyl oxidase involving IL-6, Fli1, and epigenetic DNA methylation | Q41986504 | ||
| Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential | Q42472805 | ||
| Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha | Q42513418 | ||
| N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction | Q42555798 | ||
| Dermatan sulphate-rich proteoglycan associates with rat tail-tendon collagen at the d band in the gap region | Q42658056 | ||
| Long-term treatment with lanthanum carbonate reduces mineral and bone abnormalities in rats with chronic renal failure | Q42745707 | ||
| Regulation of lysyl oxidase by basic fibroblast growth factor in osteoblastic MC3T3-E1 cells | Q42815294 | ||
| Differential effects of homocysteine and beta aminopropionitrile on preosteoblastic MC3T3-E1 cells. | Q42832433 | ||
| Effect of asymmetric dimethylarginine on osteoblastic differentiation | Q43795974 | ||
| Homocysteine and C-reactive protein levels in haemodialysis patients | Q44046660 | ||
| Nonenzymatic cross-linking pentosidine increase in bone collagen and are associated with disorders of bone mineralization in dialysis patients | Q44414030 | ||
| Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis | Q44460288 | ||
| Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats | Q44503816 | ||
| Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism | Q44605245 | ||
| Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls | Q46281109 | ||
| Effects of cytokines on alkaline phosphatase and osteocalcin production, calcification and calcium release by human osteoblastic cells | Q46295562 | ||
| Post-translational control of collagen fibrillogenesis in mineralizing cultures of chick osteoblasts | Q46296110 | ||
| Treatment of experimental renal osteodystrophy with pamidronate | Q46607026 | ||
| Comparison of chronic renal failure rats and modification of the preparation protocol as a hyperphosphataemia model | Q46753404 | ||
| Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia. | Q46823232 | ||
| The influence of inflammation-mediated osteopenia (IMO) on the structure of rabbit bone and skin collagen fibrils | Q47918816 | ||
| Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis. | Q50991780 | ||
| Quantitative microcomputed tomography assessment of intratrabecular, intertrabecular, and cortical bone architecture in a rat model of severe renal osteodystrophy. | Q51917994 | ||
| Renal function and risk of hip and vertebral fractures in older women. | Q51924728 | ||
| Association of kidney function with incident hip fracture in older adults. | Q53245136 | ||
| Multi-detector row CT imaging of vertebral microstructure for evaluation of fracture risk. | Q53570353 | ||
| PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. | Q53607251 | ||
| Lysyl oxidase (LOX) down-regulation by TNFα: A new mechanism underlying TNFα-induced endothelial dysfunction | Q60923974 | ||
| Renal osteodystrophy studies with scanning and transmission electron microscopy | Q67669211 | ||
| Animal model of adenine-induced chronic renal failure in rats | Q69671435 | ||
| Corneal and scleral collagen fiber formation in vitro | Q70968243 | ||
| Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia | Q71512064 | ||
| Collagen fibril diameter and its relation to cross-linking of collagen in the skin of patients with amyotrophic lateral sclerosis | Q72621718 | ||
| Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure | Q72681292 | ||
| Regulation of lysyl oxidase expression in lung fibroblasts by transforming growth factor-beta 1 and prostaglandin E2 | Q72769876 | ||
| Three-dimensional analysis of the spine in autopsy cases with renal osteodystrophy | Q72898089 | ||
| Morphometric analysis of type I collagen fibrils in the osteoid of osteogenesis imperfecta | Q73132767 | ||
| Structural alterations in rat skin and bone collagen fibrils induced by ovariectomy | Q73553548 | ||
| Mechanisms for the formation of glycoxidation products in end-stage renal disease | Q73873585 | ||
| Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria | Q73956052 | ||
| Increased risk of hip fracture among patients with end-stage renal disease | Q73969374 | ||
| Functional importance of connective tissue repair during the development of experimental abdominal aortic aneurysms | Q74242737 | ||
| A bridge to improving healthcare outcomes and quality of life | Q76380709 | ||
| Disparate effects of mild, moderate, and severe secondary hyperparathyroidism on cancellous and cortical bone in rats with chronic renal insufficiency | Q77298539 | ||
| The role of collagen in the declining mechanical properties of aging human cortical bone | Q77975607 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1170-1183 | |
| P577 | publication date | 2013-08-26 | |
| P1433 | published in | Laboratory Investigation | Q6467260 |
| P1476 | title | Advanced glycation end products suppress lysyl oxidase and induce bone collagen degradation in a rat model of renal osteodystrophy | |
| P478 | volume | 93 |
| Q90153610 | Bone Mineral Is More Heterogeneously Distributed in the Femoral Heads of Osteoporotic and Diabetic Patients: A Pilot Study |
| Q30873913 | Changes in skeletal collagen cross-links and matrix hydration in high- and low-turnover chronic kidney disease |
| Q35661168 | Compromised vertebral structural and mechanical properties associated with progressive kidney disease and the effects of traditional pharmacological interventions |
| Q33727902 | Cortical bone mechanical properties are altered in an animal model of progressive chronic kidney disease |
| Q38965115 | Derangement of calcium metabolism in diabetes mellitus: negative outcome from the synergy between impaired bone turnover and intestinal calcium absorption |
| Q38384409 | Effects of Collagen Crosslinking on Bone Material Properties in Health and Disease |
| Q51811153 | Insulin does not rescue cortical and trabecular bone loss in type 2 diabetic Goto-Kakizaki rats. |
| Q37631469 | Lysyl Oxidase and the Tumor Microenvironment |
| Q30234751 | Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease. |
| Q90592532 | N-acetylcysteine (NAC), an anti-oxidant, does not improve bone mechanical properties in a rat model of progressive chronic kidney disease-mineral bone disorder |
| Q104486526 | Pentosidine and carboxymethyl-lysine associate differently with prevalent osteoporotic vertebral fracture and various bone markers |
| Q90340272 | Responses of primary osteoblasts and osteoclasts from hemizygous β-globin knockout thalassemic mice with elevated plasma glucose to 1,25-dihydroxyvitamin D3 |
| Q57150277 | Serum 25-hydroxyvitamin D is associated with advanced glycation end products (AGEs) measured as skin autofluorescence: The Rotterdam Study |
| Q35691361 | Update on type 2 diabetes-related osteoporosis |
Search more.